Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease

Atherosclerosis is the leading cause of death worldwide, especially in patients with type 2 diabetes mellitus (T2D). GLP-1 receptor agonists and DPP-4 inhibitors were demonstrated to play a markedly protective role for the cardiovascular system beyond their glycemic control. Several cardiovascular o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernardini, Federico, Nusca, Annunziata, Coletti, Federica, La Porta, Ylenia, Piscione, Mariagrazia, Vespasiano, Francesca, Mangiacapra, Fabio, Ricottini, Elisabetta, Melfi, Rosetta, Cavallari, Ilaria, Ussia, Gian Paolo, Grigioni, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386670/
https://www.ncbi.nlm.nih.gov/pubmed/37514043
http://dx.doi.org/10.3390/pharmaceutics15071858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386670/
https://www.ncbi.nlm.nih.gov/pubmed/37514043
http://dx.doi.org/10.3390/pharmaceutics15071858

Ejemplares similares